Previous reports have supported a role for COL6A3 in inflammation obesity and obesity-associated insulin resistance which may lead to a higher incidence and more rapid progression of diabetes complications (47, 48). Here, COL6A3 is linked to obesity due to melanocortin 4 receptor deficiency.